Observatory · observe first
Moderna
MRNA · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
0.249%
12M weight contribution
-0.081 pp
3M weight contribution
+0.067 pp
12M price return
-29.3%
Share of matched S&P 500 members
Monthly observations through Dec 2022
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Dec 2022 | $69.0bn | 0.249% | -0.081 pp | -29.3% | Yes |
| Nov 2022 | $67.6bn | 0.229% | -0.253 pp | -50.1% | Yes |
| Oct 2022 | $58.8bn | 0.209% | -0.257 pp | -56.5% | Yes |
| Sep 2022 | $46.3bn | 0.182% | -0.364 pp | -69.3% | No |
| Aug 2022 | $51.7bn | 0.185% | -0.323 pp | -64.9% | No |
| Jul 2022 | $65.3bn | 0.224% | -0.263 pp | -53.6% | Yes |
| Jun 2022 | $56.8bn | 0.221% | +0.221 pp | -39.2% | Yes |
| May 2022 | $57.8bn | 0.208% | +0.208 pp | -21.4% | No |
| Apr 2022 | $54.2bn | 0.196% | +0.196 pp | -24.8% | No |
| Mar 2022 | $69.4bn | 0.234% | +0.234 pp | +31.5% | No |
| Feb 2022 | $61.9bn | 0.215% | +0.215 pp | -0.8% | No |
| Jan 2022 | $68.7bn | 0.231% | +0.231 pp | -2.2% | No |
| Dec 2021 | $103.0bn | 0.330% | +0.330 pp | +143.1% | No |
| Nov 2021 | $142.9bn | 0.483% | +0.483 pp | +130.7% | Yes |
| Oct 2021 | $139.3bn | 0.465% | +0.465 pp | +411.6% | Yes |
| Sep 2021 | $155.3bn | 0.545% | +0.545 pp | +444.0% | Yes |
| Aug 2021 | $152.1bn | 0.508% | +0.508 pp | +480.5% | Yes |
| Jul 2021 | $142.0bn | 0.487% | +0.487 pp | +377.2% | Yes |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.